SCHEMBL19436612

SCHEMBL19436612

Cc1nc(C)c2c(n1)Nc1ccccc1C(=O)N2C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GFER P55789 1/20 0.37
▸ KDM4E B2RXH2 6/20 0.37
▸ ALDH1A1 P00352 6/20 0.37
▸ GAA P10253 3/20 0.37
▸ LMNA P02545 2/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ CASP3 P42574 1/20 0.37
▸ POLB P06746 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ RECQL P46063 1/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ HPGD P15428 3/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ CASP1 P29466 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ MAOA P21397 1/20 0.34
▸ MAOB P27338 1/20 0.34
▸ PDGFRA P16234 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16980134 0.69 POLB (0.39) GFERKDM4EALDH1A1GAALMNA
SCHEMBL11486350 0.68 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2CYP1A2
SCHEMBL24334888 0.67 CASP3 (0.38) GFERKDM4EALDH1A1CASP3POLB
SCHEMBL7982510 0.66 TTR (0.55) GFERKDM4EALDH1A1GAALMNA
SCHEMBL29583687 0.66 CASP3 (0.40) GFERKDM4EALDH1A1GAATDP1
SCHEMBL11526334 0.64 ALDH1A1 (0.42) KDM4EALDH1A1GAALMNACASP3
SCHEMBL8968026 0.62 MAPT (0.38) KDM4EALDH1A1GAACASP3POLB
SCHEMBL5937266 0.62 ALDH1A1 (0.66) ALDH1A1GAASMN1; SMN2CYP1A2
SCHEMBL27089618 0.62 CHEK1 (0.55) KDM4EALDH1A1GAALMNATDP1
SCHEMBL29511191 0.61 CASP3 (0.81) KDM4EALDH1A1CASP3POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3440084-A1 PYRIMIDO-DIAZEPINONE KINASE SCAFFOLD COMPOUNDS AND METHODS OF TREATING PI3K-MEDIATED DISORDERS Dana-Farber Cancer Institute, Inc. (US) 2019-02-13 — — EP disclosed
WO-2017177092-A1 PYRIMIDO-DIAZEPINONE KINASE SCAFFOLD COMPOUNDS AND METHODS OF TREATING PI3K-MEDIATED DISORDERS DANA-FARBER CANCER INSTITUTE, INC. (US) 2017-10-12 — — WO disclosed
Send feedback